DSS Inc

Aktienanalyse zu DSS Inc (DSS)

$0.537

-0.007 (-1.23%)Zum Schluss

Loading chart…
High
0.538
Open
0.538
VWAP
0.54
Vol
2.09K
Mkt Cap
12.39M
Low
0.537
Amount
1.12K
EV/EBITDA, TTM
0.00

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

AI analysis of DSS Inc (DSS)

hold

DSS Inc is not a strong buy at this moment due to significant financial losses and high debt levels. The current price is $0.54, with a year-to-date change of -43.78% and a gross margin of -25.39%. The main risk is the company's high debt-to-equity ratio of 62.39%, indicating potential financial instability.

Bewertungskennzahlen

The current forward P/E ratio for DSS Inc (DSS) is 0.00, compared to its 5-year average forward P/E of -1.51.

Forward P/E

Overvalued
5Y Average P/E
-1.51
Current P/E
0.00
Überbewertet
-0.56
Unterbewertet
-2.46

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-5.75
Current EV/EBITDA
0.00
Überbewertet
1.08
Unterbewertet
-12.59

Forward P/S

Undervalued
5Y Average P/S
0.73
Current P/S
0.00
Überbewertet
1.35
Unterbewertet
0.12

Alphio AI Price Scenarios for DSS

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%DSS

$0.63

Szenariopreis

B

Base

Base · 50%DSS

$0.63

Szenariopreis

B

Bear

Bear · 25%DSS

$0.61

Szenariopreis

Event-Zeitleiste

2026-05-08 (ET)

17:10:00

DSS Annual Report Contains Going Concern Audit Opinion

2026-02-04 (ET)

08:40:00

DSS Prices Public Offering Expected to Raise $1M

2026-02-03 (ET)

20:30:00

Aegis Capital Acts as Sole Underwriter for Offering

2025-06-24 (ET)

08:33:48

DSS' Impact BioMedical announces strategic merger with Dr. Ashley's

2025-05-22 (ET)

08:32:59

DSS reports Q1 EPS (55c) vs. (58c) last year

News

DSS FAQ — answered by Alphio AI

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing. It operates in the Basic Materials sector (PAPERBOARD CONTAINERS & BOXES industry).

DSS Inc is not a strong buy at this moment due to significant financial losses and high debt levels. The current price is $0.54, with a year-to-date change of -43.78% and a gross margin of -25.39%. The main risk is the company's high debt-to-equity ratio of 62.39%, indicating potential financial instability.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten